136511-43-8

136511-43-8 structure

Name: SCH 42495
Chemical Name: N-[2(S)-(acetylhtiomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine ethyl ester
CAS Number: 136511-43-8
Molecular Formula: C₂₀H₂₉NO₄S₂
Molecular Weight: 411.57900
Catalog: Signaling Pathways Metabolic Enzyme/Protease Neprilysin
Create Date: 2016-02-06 00:38:29
Modify Date: 2025-09-10 07:47:02
SCH 42495 is an orally active neutral metalloendopeptidase (NEP) inhibitor with antihypertensive effect. SCH 42495 is the orally active ethylester prodrug of SCH 42354[1].

Name	N-[2(S)-(acetylhtiomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine ethyl ester
Synonyms	N-(2(S)-(ACETYLTHIOMETHYL)-3-(2-METHYLPHENYL)-1-OXOPROPYL)-L-METHIONINE ETHYL ESTER N-[2(S)-acetylthiomethyl-3-(2-methylphenyl)propionyl]-(S)-methionine ethyl ester

Description	SCH 42495 is an orally active neutral metalloendopeptidase (NEP) inhibitor with antihypertensive effect. SCH 42495 is the orally active ethylester prodrug of SCH 42354[1].
Related Catalog	Research Areas >> Cardiovascular Disease Signaling Pathways >> Metabolic Enzyme/Protease >> Neprilysin
Target	NEP[1]
In Vitro	SCH 42354 selectively inhibits hydrolysis of leu-enkephalin and ANF (IC50 of 8.3 and 10.0 nM, respectively) in vitro[1].
In Vivo	SCH 42495 (30 mg/kg; oral gavage; twice daily) causes a significant reduction in the pulmonary vascular remodelling and ventricular hypertrophy in hypoxic rats after 10 days[2]. Treatment with SCH 42495 (30 mg/kg; oral gavage; twice daily) leads to a decrease in cardiovascular remodelling secondary to chronic hypoxia in rats[2]. SCH 42495 (oral doses of 1, 3, or 10 mg/kg) produces significant reductions in blood pressure in DOCA-N a hypertensive rats of 22±6, 43±7, and 62±12 mm Hg, respectively[1]. Animal Model: Hypoxic rats[2] Dosage: 30 mg/kg Administration: Oral gavage; twice daily for 10 days Result: Caused a significant reduction in the pulmonary vascular remodelling and ventricular hypertrophy. Led to a decrease in cardiovascular remodelling secondary to chronic hypoxia.
References	[1]. Watkins RW, et al. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor. Am J Hypertens. 1993 May;6(5 Pt 1):357-68. [2]. Thompson JS, et al. Effects of the neutral endopeptidase inhibitor, SCH 42495, on the cardiovascular remodelling secondary to chronic hypoxia in rats. Clin Sci (Lond). 1994 Jul;87(1):109-14.

Molecular Formula	C₂₀H₂₉NO₄S₂
Molecular Weight	411.57900
Exact Mass	411.15400
PSA	123.07000
LogP	3.62530

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

136511-43-8	156792-25-5
145841-10-7	1227675-51-5
473728-58-4	174648-45-4
322473-89-2	39624-66-3
160098-96-4	444659-43-2
2228248-67-5	2229499-92-5
2228968-16-7	2228284-56-6
2227660-42-4	2227676-07-3
2228831-82-9	2229634-60-8
2227791-42-4	2228941-64-6